Literature DB >> 9593758

The binding of some human antiendothelial cell antibodies induces endothelial cell apoptosis.

A Bordron1, M Dueymes, Y Levy, C Jamin, J P Leroy, J C Piette, Y Shoenfeld, P Y Youinou.   

Abstract

The pathogenic role of antiendothelial cell antibodies (AECA) remains unclear. They are frequently associated with antibodies to anionic phospholipids (PL), such as phosphatidylserine (PS), which is difficult to reconcile with the distribution of PL molecular species within the plasma membrane. Since it is already known that PS is transferred to the outer face of the membrane as a preclude to apoptosis, the possibility exists that apoptosis is initiated by AECA. AECA-positive/anti-PL antibody-negative sera from eight patients with systemic sclerosis (SS) and 21 control patients were evaluated. Endothelial cells (EC) were incubated with AECA and the exposure of PS was established through the binding of annexin V. Hypoploid cell enumeration, DNA fragmentation, and optical and ultrastructural analyses of EC were used to confirm apoptosis. Incubation of EC with AECA derived from six of eight patients with SS led to the expression of PS on the surface of the cells. This phenomenon was significantly more frequent in SS (P < 0.04) than in control diseases. The redistribution of plasma membrane PS preceded other events associated with apoptosis: hypoploidy, DNA fragmentation, and morphology characteristic for apoptosis. Apoptosis-inducing AECA did not recognize the Fas receptor. We conclude that AECA may be pathogenic by inducing apoptosis.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9593758      PMCID: PMC508790          DOI: 10.1172/JCI2261

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  28 in total

1.  The American College of Rheumatology 1990 criteria for the classification of giant cell arteritis.

Authors:  G G Hunder; D A Bloch; B A Michel; M B Stevens; W P Arend; L H Calabrese; S M Edworthy; A S Fauci; R Y Leavitt; J T Lie
Journal:  Arthritis Rheum       Date:  1990-08

2.  The American College of Rheumatology 1990 criteria for the classification of Takayasu arteritis.

Authors:  W P Arend; B A Michel; D A Bloch; G G Hunder; L H Calabrese; S M Edworthy; A S Fauci; R Y Leavitt; J T Lie; R W Lightfoot
Journal:  Arthritis Rheum       Date:  1990-08

3.  Involvement of apoptosis antigen Fas in clonal deletion of human thymocytes.

Authors:  S Yonehara; Y Nishimura; S Kishil; M Yonehara; K Takazawa; T Tamatani; A Ishii
Journal:  Int Immunol       Date:  1994-12       Impact factor: 4.823

4.  Fas ligation triggers apoptosis in macrophages but not endothelial cells.

Authors:  B C Richardson; N D Lalwani; K J Johnson; R M Marks
Journal:  Eur J Immunol       Date:  1994-11       Impact factor: 5.532

5.  Interview with Pier-Luigi Meroni. What is going to happen tomorrow in the field of anti-endothelial cell autoantibodies related to vasculitis?

Authors:  P L Meroni
Journal:  Ann Med Interne (Paris)       Date:  1994

6.  A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry.

Authors:  I Nicoletti; G Migliorati; M C Pagliacci; F Grignani; C Riccardi
Journal:  J Immunol Methods       Date:  1991-06-03       Impact factor: 2.303

7.  Exposure of phosphatidylserine on the surface of apoptotic lymphocytes triggers specific recognition and removal by macrophages.

Authors:  V A Fadok; D R Voelker; P A Campbell; J J Cohen; D L Bratton; P M Henson
Journal:  J Immunol       Date:  1992-04-01       Impact factor: 5.422

8.  Apoptosis induced in Burkitt's lymphoma cells via Gb3/CD77, a glycolipid antigen.

Authors:  M Mangeney; C A Lingwood; S Taga; B Caillou; T Tursz; J Wiels
Journal:  Cancer Res       Date:  1993-11-01       Impact factor: 12.701

9.  Role of beta 2-glycoprotein I in the antiphospholipid antibody binding to endothelial cells.

Authors:  M Le Tonquèze; K Salozhin; M Dueymes; J C Piette; V Kovalev; Y Shoenfeld; E Nassonov; P Youinou
Journal:  Lupus       Date:  1995-06       Impact factor: 2.911

10.  Stimulation of von Willebrand factor antigen release by immunoglobulin from thrombosis prone patients with systemic lupus erythematosus and the anti-phospholipid syndrome.

Authors:  N J Lindsey; R A Dawson; F I Henderson; M Greaves; P Hughes
Journal:  Br J Rheumatol       Date:  1993-02
View more
  35 in total

Review 1.  Anti-endothelial cell antibodies in systemic sclerosis.

Authors:  Y Renaudineau; R Revelen; Y Levy; K Salojin; B Gilburg; Y Shoenfeld; P Youinou
Journal:  Clin Diagn Lab Immunol       Date:  1999-03

2.  Functional heterogeneity of anti-endothelial cell antibodies.

Authors:  A Bordron; R Révélen; F D'Arbonneau; M Dueymes; Y Renaudineau; C Jamin; P Youinou
Journal:  Clin Exp Immunol       Date:  2001-06       Impact factor: 4.330

3.  Effects of anti-endothelial cell antibodies in leprosy and malaria.

Authors:  Christophe Dugué; Ronald Perraut; Pierre Youinou; Yves Renaudineau
Journal:  Infect Immun       Date:  2004-01       Impact factor: 3.441

4.  Detection of antiendothelial cell antibodies by an enzyme-linked immunosorbent assay using antigens from cell lysate: minimal interference with antinuclear antibodies and rheumatoid factors.

Authors:  Christian Drouet; Marie-France Nissou; Denise Ponard; Josiane Arvieux; Chantal Dumestre-Pérard; Philippe Gaudin; Bernard Imbert; Christian Massot; Françoise Sarrot-Reynauld
Journal:  Clin Diagn Lab Immunol       Date:  2003-09

5.  Induction of elastin expression in vascular endothelial cells relates to hepatoportal sclerosis in idiopathic portal hypertension: possible link to serum anti-endothelial cell antibodies.

Authors:  Y Sato; X S Ren; K Harada; M Sasaki; H Morikawa; S Shiomi; M Honda; S Kaneko; Y Nakanuma
Journal:  Clin Exp Immunol       Date:  2012-03       Impact factor: 4.330

Review 6.  Antiendothelial cell antibodies in vasculitis and connective tissue disease.

Authors:  C Belizna; A Duijvestijn; M Hamidou; J W Cohen Tervaert
Journal:  Ann Rheum Dis       Date:  2006-03-28       Impact factor: 19.103

Review 7.  HSP60 and anti-HSP60 antibodies in vasculitis: they are two of a kind.

Authors:  Jean-Eric Alard; Maryvonne Dueymes; Pierre Youinou; Christophe Jamin
Journal:  Clin Rev Allergy Immunol       Date:  2008-10       Impact factor: 8.667

Review 8.  Pathogenesis of systemic sclerosis-current concept and emerging treatments.

Authors:  Masutaka Furue; Chikage Mitoma; Hiroki Mitoma; Gaku Tsuji; Takahito Chiba; Takeshi Nakahara; Hiroshi Uchi; Takafumi Kadono
Journal:  Immunol Res       Date:  2017-08       Impact factor: 2.829

Review 9.  Inflammation and immunity in the pathogenesis of pulmonary arterial hypertension.

Authors:  Marlene Rabinovitch; Christophe Guignabert; Marc Humbert; Mark R Nicolls
Journal:  Circ Res       Date:  2014-06-20       Impact factor: 17.367

10.  Qualitative and quantitative studies of autoantibodies to phospholipids in diabetes mellitus.

Authors:  P Gargiulo; J Goldberg; B Romani; R Schiaffini; P Ciampalini; W P Faulk; J A McIntyre
Journal:  Clin Exp Immunol       Date:  1999-10       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.